Astrana Health Inc. · NASDAQ:ASTH
Astrana Health — Apollo Medical Holdings — Q1 2022 Earnings Presentation
6 slides from Astrana Health's earnings presentation, May 5, 2022
Slide 1: Forward-Looking Statements
Forward-Looking Statements This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act and Section 21E of the Exchange Act. Forward-looking statements include any statements about the Company's bu
Slide 2: ApolloMed At-A-Glance
25+ years of operation “IPA: independent physician association As of 4/30/2022 ApolloMed At-A-Glance Ticker 9,600+ contracted Headquarters physicians Employees (as of 12/31/2021) Recent Stock Price (as of 4/28/2022) Market Cap (as of 4/28/2022) Common Shares Outstanding (as of 4/28/2022) Book Value
Slide 3: Historical revenue growth and net income growth
Historical revenue growth Historical net income attributable (Sinmilions) to ApolloMed growth ($inmillions) $1,070 $73.9 $774 $687 $520 $561 $37.9 [ i _ = 2018 2019 = 2020-2 -2021.-~S 2022" 2018 2019 2020 2021 * midpoint of 2022 guidance range
Slide 4: Revenue mix for the three months ended March 31, 2022
100% 90% 80% 70% 60% 50% 40% 30% 20% 10% 0% = Capitation = Risk Pool Settlements & Incentives Management Fee income uFee-for-service, net = Other Income For the three months ended March 31, 2022 (a) Capitation - Capitated fees for medical services via direct arrangements with managed care providers.
Slide 5: Revenue by payer: Medicare, Medicaid, Commercial, Other
I Medicare © Medicaid Commercial I Other Third Parties
Slide 6: ApolloMed Investor Relations
apollomed ApolloMed Investor Relations (626) 943-6491 investors@apollomed.net Carolyne Sohn, The Equity Group (415) 568-2255 csohn@equityny.com
Apollo Medical Holdings — Q1 2022 Earnings Presentation on 6ix